AstraZeneca Vaccine Snag Casts Shadow Over Market Rally

With millions of lives and livelihoods hanging in the balance, the need for a safe and effective Covid-19 vaccine is red-lining. Unfortunately, near-term hopes for a game-saving vaccine took a big hit on Sept. 8 when AstraZeneca (AZN) announced the company was temporarily pausing its Phase 3 coronavirus vaccine trials. This development is especially deflating … Continued